跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nepalact - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nepalact
Approved
STANDARD
Nepalact
Sun Pharmaceutical Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e8718f8f984a0ac0
Company
Sun Pharmaceutical Medicare Limited
Type
Standard
Approval Details
Approval Id
e8718f8f984a0ac0
Drug Approval Philippines Name
Nepalact
Product Name
Nepalact
Registration Number
DR-XY45971
Brand Name
Nepalact
Generic Name
Nepafenac
Dosage Form
Sterile Ophthalmic Suspension (Eye Drops)
Dosage Strength
1 mg/mL (0.1% w/v)
Manufacturer
Sun Pharmaceutical Medicare Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-medicare-limited
Issuance Date
07 August 2024
Expiry Date
07 August 2029
Pharmacologic Category
Non-Steroidal Anti-inflammatory Drug (NSAID)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e8718f8f984a0ac0
Type
Standard
Back to Philippines FDA Approvals